Sirmon Singh

Company: Sunnybrook Research Institute

Job title: Med Onc

Seminars:

Revealing Results of Phase Three Randomized NETTER-2 Novartis Trial to Explore a First Line Treatment for NET 9:15 am

To discuss the results of the NETTER 2 clinical trial To review the current use of RLT in first line treatment of cancer To understand the role of RLT in aggressive NET diseaseRead more

day: Conference Day One

Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress 8:30 am

Exploring PSMA updates and predictions for the future market of prostate cancer drugs Pricing and reimbursement considerations in a competitive market Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64Read more

day: Conference Day One